eli lilly glp-1 medications portfolio The weight-loss landscape just reached a major turning point. On April 9, 2026, officially launched Foundayo™, its highly anticipated oral therapy, kicking off a direct showdown with Novo Nordisk's Eli Lilly was just another

However, given the scarcity of studies, this pattern must be interpreted cautiously

Be sure to talk to your healthcare professional about the best protocol for you

Over 300 major drugs in the U.S

Gabriel Iglesias Funnyman Gabriel Iglesias turned to Ozempic to get his weight under control

FDA-approved for improving glycemic control in adults with type 2 diabetes and for reducing the risk of major adverse cardiovascular events in certain adults with type 2 diabetes and established cardiovascular disease

Their multifaceted mechanismsincluding weight loss, improved glycemic control, anti-inflammatory effects, and lipid profile enhancementcontribute to substantial cardiovascular benefits